Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.44Price to Earnings
VS
Market
Sector
Industry
History
$ 29.46Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information
Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRIGEL PHARMACEUTICALS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RIGL - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 434.8M | $ 97.82M | 4.44 |
| 3/31/2025 | $ 326.35M | $ 37.18M | 8.78 |
| 12/31/2024 | $ 394.41M | $ 17.48M | 22.56 |
| 9/30/2024 | $ 271.98M | $ 3.88M | 70.08 |
| 6/30/2024 | $ 164.16M | $ -14.23M | 0 |
| 3/31/2024 | $ 208.73M | $ -19.8M | 0 |
| 12/31/2023 | $ 259.56M | $ -25.09M | 0 |
| 9/30/2023 | $ 151.79M | $ -24.43M | 0 |
| 6/30/2023 | $ 231.9M | $ -37.77M | 0 |
| 3/31/2023 | $ 197.98M | $ -44.66M | 0 |
Key Performance Insights, Last 5 Years
- RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, RIGEL PHARMACEUTICALS INC's average P/E has been 26.46.
- The median P/E for RIGEL PHARMACEUTICALS INC during this period was 15.67
- RIGEL PHARMACEUTICALS INC reached its highest P/E over the past 5 years at 70.08.
- The lowest P/E recorded by RIGEL PHARMACEUTICALS INC in the same timeframe 4.44
RIGEL PHARMACEUTICALS INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for RIGEL PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 463.01M ] / Net Inc. Cmn. [ $ -27.71M ]
(=) P/E [ 0 ] RIGL - Price to Earnings, Last 5 years
4.44
Minimum
Jun 30, 2025
70.08
Maximum
Sep 30, 2024
26.46
Average
15.67
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |